Call

Rapid Diagnostic Tests Explained: Comparing Flu, COVID-19, RSV, and Strep A Testing Options

0

When respiratory symptoms appear, one of the first questions people ask is, β€œIs it the flu, COVID-19, RSV, or something else?” These infections can share symptoms, including fever, coughing, fatigue, congestion, and a sore throat. Because the symptoms can overlap, identifying the possible cause may require appropriate diagnostic testing rather than relying on symptoms alone.

Rapid diagnostic tests help healthcare professionals obtain timely information about specific infections and determine whether additional evaluation or testing may be necessary. However, not every test detects the same pathogen, uses the same specimen, or serves the same purpose.

At Atlantic Medical Supplies, based in Robbinsville, New Jersey, healthcare professionals can explore diagnostic options such as CorDx Flu/Covid, CorDx RSV Test, Healgen Rapid Check COVID-19/Flu A&B Pro, and Strep A Rapid Test. Understanding how these products differ can help clinics, healthcare facilities, and purchasing teams make more informed supply decisions.

In this guide, we compare the four testing options, explain their intended uses, discuss important purchasing considerations, and answer common questions about rapid diagnostic testing.

What Are Rapid Diagnostic Tests?

Rapid diagnostic tests are medical tests designed to detect specific markers of an infection and provide results within a relatively short period. Depending on the test, these markers may include antigens associated with a virus or bacterium. Many rapid antigen tests use immunoassay technology to identify the target in a collected specimen.

Unlike tests that may require laboratory processing and longer turnaround times, some rapid tests can provide results during a healthcare visit. However, performance, specimen requirements, interpretation, and follow-up recommendations vary by product.

Rapid tests are commonly used to help identify infections such as influenza, COVID-19, respiratory syncytial virus (RSV), and Group A Streptococcus. Choosing the right test begins with understanding which pathogen it is designed to detect.

Why Do Different Infections Require Different Tests?

A fever, cough, or sore throat does not automatically identify the infection responsible. Influenza and COVID-19 can cause similar respiratory symptoms, while RSV may cause respiratory illness ranging from mild symptoms to more serious disease in vulnerable individuals. Group A Streptococcus, meanwhile, is a bacterium associated with conditions such as strep throat.

A test designed to detect one pathogen cannot automatically detect another. Even when two products look similar, their intended targets, collection procedures, and interpretation requirements may differ.

For example:

  • COVID-19 and flu tests can identify SARS-CoV-2 and/or influenza antigens, depending on the product.
  • RSV tests are designed to detect markers associated with respiratory syncytial virus.
  • Strep A tests detect markers associated with Group A Streptococcus, generally using a throat swab.
  • Combination tests can evaluate multiple specified targets in one testing process.

For healthcare providers, matching the test to the clinical question is more important than selecting a product simply because it offers a quick result.

CorDx Flu/Covid: Testing for COVID-19 and Influenza A and B

The CorDx Flu/Covid product available from Atlantic Medical Supplies is the CorDx Tyfast Flu A/B and COVID-19 Multiplex Rapid Test. It is a lateral flow immunoassay intended for the qualitative detection and differentiation of SARS-CoV-2 and influenza A and B antigens.

This combination approach is useful to understand because COVID-19 and influenza can produce overlapping symptoms. A test that evaluates all three specified targets can provide more information than a test designed to detect only one of them.

What should healthcare professionals know about CorDx Flu/Covid?

When evaluating this product, consider its intended use, specimen requirements, testing procedure, result interpretation, and the instructions supplied by the manufacturer. A combination test may help streamline the testing process, but it does not eliminate the need to consider other possible causes of symptoms.

Healthcare facilities should also confirm the specific product configuration and its applicable regulatory status before ordering.

Explore the product: CorDx Flu/Covid at Atlantic Medical Supplies

CorDx RSV Test: Understanding RSV Detection

Respiratory syncytial virus, commonly known as RSV, is a respiratory virus that can affect people of different ages. Although many infections cause mild, cold-like symptoms, RSV can lead to more serious respiratory illness in infants, older adults, and certain people with underlying health conditions.

The CorDx RSV Test is a rapid immunochromatographic assay intended for the qualitative detection of RSV nucleoprotein antigen. Its specific target distinguishes it from tests designed to identify influenza or SARS-CoV-2.

When is RSV testing relevant?

RSV testing may be considered when a healthcare professional needs information about a suspected RSV infection. Symptoms alone cannot reliably distinguish RSV from every other respiratory infection, so the decision to test should reflect the patient’s presentation and the test’s intended use.

When purchasing an RSV test, healthcare facilities should review:

  • The specified specimen type and collection procedure.
  • The test’s intended population and use.
  • The manufacturer’s storage and handling requirements.
  • The instructions for interpreting results.
  • Whether further testing or clinical evaluation may be needed.

A negative result does not necessarily exclude RSV infection. Interpretation should account for the test’s performance, the timing of specimen collection, symptoms, and applicable clinical guidance.

Explore the product: CorDx RSV Test at Atlantic Medical Supplies

Healgen Rapid Check COVID-19/Flu A&B Pro: Three Respiratory Targets in One Test

The Healgen Rapid Check COVID-19/Flu A&B Pro is another combination testing option. According to its product information, this lateral flow immunochromatographic assay is intended for the qualitative detection and differentiation of influenza A nucleoprotein antigens, influenza B nucleoprotein antigens, and SARS-CoV-2 nucleocapsid antigen from anterior nasal swab specimens.

The product provides results in approximately 15 minutes and is intended for professional use and in vitro diagnostic use, according to its labeling.

What makes this combination test useful to compare?

Its three-target design means that one test can evaluate for COVID-19, influenza A, and influenza B. This may be helpful when symptoms overlap and testing for multiple respiratory viruses is appropriate.

The product information also identifies two result windows and multiple kit-size options. Available configurations include 10-test and 25-test kits, so buyers can compare packaging against their expected testing volume.

Before ordering, healthcare professionals should verify the exact product configuration and follow its current instructions. The listed intended use specifies that individuals aged 14 or older may self-test, while adults may test individuals aged two or older; children aged two through 13 must have their swab collected by an adult. Facilities should confirm that the intended use matches their setting.

An important limitation: Negative results are considered presumptive and may require confirmation with an FDA-cleared molecular assay when a healthcare provider determines it is appropriate. A positive result also does not rule out infection with another respiratory pathogen.

Explore the product: Healgen Rapid Check COVID-19/Flu A&B Pro at Atlantic Medical Supplies

Strep A Rapid Test: A Different Approach to Sore Throat Testing

Not every infection associated with respiratory symptoms is caused by a virus. Group A Streptococcus is a bacterium that can cause strep throat, which may involve a sore throat, pain when swallowing, and fever.

The Strep A Rapid Test available from Atlantic Medical Supplies is a rapid antigen test intended to aid in identifying Group A Streptococcal infection from a human throat swab specimen. Unlike the CorDx Flu/Covid and Healgen combination tests, it is designed to detect a bacterial target rather than influenza and COVID-19 antigens.

What should buyers know about the Strep A Rapid Test?

The product listing identifies an approximate five-minute result time, room-temperature storage, and both strip and cassette configurations. Some specific configurations are identified as CLIA-waived and include FDA 510(k) clearance; the regulatory status depends on the selected catalog number.

For healthcare purchasing teams, that distinction matters. Not every version should be assumed to have identical regulatory status or packaging.

Before placing an order, check the test format, kit size, control requirements, and exact regulatory designation. Clinicians should also interpret results according to the product instructions and applicable clinical guidance. Depending on the patient and circumstances, a negative rapid antigen result may not be the end of the diagnostic process.

Explore the product: Strep A Rapid Test at Atlantic Medical Supplies

Comparing the Four Rapid Diagnostic Tests

The main difference between these products is what each one is designed to detect. Their result times and specimen requirements also differ, so they should not be treated as interchangeable.

ProductIntended targetsSpecimenApproximate result time
CorDx Flu/CovidSARS-CoV-2, influenza A and B antigensFollow current product instructionsVerify current product labeling
CorDx RSV TestRSV nucleoprotein antigenFollow current product instructionsVerify current product labeling
Healgen Rapid Check COVID-19/Flu A&B ProSARS-CoV-2, influenza A and B antigensAnterior nasal swab15 minutes
Strep A Rapid TestGroup A Streptococcus antigenHuman throat swab5 minutes

Result times and specimen requirements should always be confirmed against the specific product’s current instructions. A shorter turnaround time does not automatically mean a test is more accurate or more appropriate for a particular patient.

The table illustrates why test selection should start with the pathogen being investigated. If a healthcare professional needs to evaluate for RSV, for instance, a product designed only for COVID-19 and influenza will not answer that question.

Similarly, a throat-swab test for Group A Streptococcus serves a different purpose from a nasal-swab combination test for respiratory viruses.

How Should Healthcare Facilities Choose the Right Rapid Test?

Selecting a diagnostic product involves more than comparing prices or advertised result times. Healthcare facilities should consider the intended use, testing workflow, regulatory requirements, and practical demands of their setting.

1. Identify the target pathogen

Start by identifying which infection or infections the test is designed to detect. Combination testing may be appropriate when multiple respiratory viruses are being considered, while a dedicated RSV or Strep A test serves a more specific purpose.

2. Confirm the specimen type

Specimen collection is a key part of test performance. The Healgen Rapid Check COVID-19/Flu A&B Pro specifies an anterior nasal swab, while the Strep A Rapid Test uses a human throat swab. Never substitute a specimen type unless the product instructions specifically permit it.

3. Review result timing and workflow

A rapid result can help healthcare teams make timely decisions, but the full workflow matters too. Consider collection, test preparation, required waiting time, result interpretation, documentation, and any follow-up procedures.

4. Check regulatory status and intended use

Confirm that the exact product and catalog number are appropriate for the intended setting. Do not assume that every variant within a product family has the same clearance, waiver, or authorization.

5. Compare kit sizes and inventory needs

Testing volume can affect which package makes practical sense. Smaller kits may suit lower-volume environments, while larger kits may be more appropriate for facilities with consistent demand. Review expiration dates, storage conditions, and stock rotation practices before purchasing.

6. Understand the limits of negative results

Rapid antigen tests may produce false-negative results. If symptoms persist or worsen, or if clinical suspicion remains high, a healthcare professional may recommend additional evaluation or molecular testing. The appropriate next step depends on the specific test, patient, and applicable guidance.

Common Mistakes to Avoid When Using Rapid Tests

Even a suitable test can be used incorrectly if the instructions or limitations are overlooked. Healthcare teams should watch for these common issues:

  • Assuming similar symptoms mean the same infection: Flu, COVID-19, RSV, and strep throat can overlap in presentation, but they require different diagnostic approaches.
  • Using the wrong specimen: Nasal and throat swabs are not automatically interchangeable.
  • Treating a negative result as definitive: A negative antigen result may not rule out infection, particularly when symptoms and other clinical information suggest otherwise.
  • Overlooking product-specific requirements: Storage conditions, age limitations, collection steps, and result-reading times vary by test.
  • Ignoring configuration differences: Different catalog numbers may have different kit sizes, controls, or regulatory designations.
  • Choosing on speed alone: Test suitability and performance matter just as much as turnaround time.

The best way to reduce avoidable errors is to train staff on the specific product being used and keep the manufacturer’s current instructions accessible.

Where Can Healthcare Professionals Find Rapid Diagnostic Tests in New Jersey?

For healthcare organizations in Robbinsville, Mercer County, and surrounding New Jersey communities, sourcing appropriate diagnostic products can be an important part of maintaining day-to-day testing supplies.

Atlantic Medical Supplies offers diagnostic products including CorDx Flu/Covid, CorDx RSV Test, Healgen Rapid Check COVID-19/Flu A&B Pro, and Strep A Rapid Test. Healthcare buyers can review the available product information and compare the options against their facility’s testing requirements.

When evaluating a supplier, look for clear product specifications, accessible ordering information, and support with identifying the appropriate product configuration. Before purchasing, confirm current pricing, availability, intended use, and any applicable regulatory requirements.

Ready to review your diagnostic supply options? Visit Atlantic Medical Supplies to explore the products and identify the tests that match your organization’s needs.

Make Informed Choices About Rapid Diagnostic Testing

Rapid diagnostic tests can support timely assessment by helping healthcare professionals identify specific pathogens, but choosing the right test requires understanding what it detects and how its results should be interpreted.

The CorDx Flu/Covid and Healgen Rapid Check COVID-19/Flu A&B Pro target COVID-19 and influenza; the CorDx RSV Test targets RSV, and the Strep A Rapid Test is designed to aid in identifying Group A Streptococcal infection. Each serves a distinct purpose, with its own specimen requirements and instructions.

For healthcare facilities in Robbinsville and across New Jersey, Atlantic Medical Supplies provides a convenient place to explore these diagnostic options. Compare the available products, review their specifications, and select the configuration that fits your facility’s needs.

Explore diagnostic products at Atlantic Medical Supplies and contact the team for product availability and ordering information.

Frequently Asked Questions About Rapid Diagnostic Tests

1. What is the difference between a rapid COVID-19 and flu test and an RSV test?

A combination COVID-19 and flu test detects specified SARS-CoV-2 and influenza antigens, while an RSV test detects markers associated with respiratory syncytial virus. They answer different diagnostic questions and are not interchangeable. The appropriate test depends on the suspected infection, the product’s intended use, and clinical guidance.

2. How quickly do rapid diagnostic tests provide results?

Turnaround times vary by product. The Healgen Rapid Check COVID-19/Flu A&B Pro lists results in approximately 15 minutes, while the Strep A Rapid Test lists results in approximately five minutes. Always follow the instructions for the exact product being used, including specimen collection and result-reading times.

3. Can a negative rapid antigen test rule out COVID-19, flu, RSV, or strep?

Not necessarily. False-negative results can occur, and test performance depends on factors such as the product, specimen collection, and timing. A healthcare professional may recommend follow-up testing when symptoms persist or clinical suspicion remains. Follow the product instructions and applicable clinical guidance.

4. What should healthcare facilities consider before buying rapid diagnostic tests?

Review the pathogen targets, intended use, specimen requirements, result time, kit size, storage conditions, control requirements, and regulatory status. Also consider testing volume, staff training, expiration dates, and inventory management. Confirm that the specific product configuration is appropriate for the intended setting before ordering.

5. Where can I buy CorDx Flu/Covid, CorDx RSV Test, Healgen Rapid Check COVID-19/Flu A&B Pro, and Strep A Rapid Test?

Healthcare buyers can explore these products through Atlantic Medical Supplies at atlanticmss.com. The company is located in Robbinsville, New Jersey, and provides online product listings for medical and diagnostic supplies. Check the relevant listing or contact the supplier for current pricing, availability, and ordering details.

Leave a Comment

Your Shopping cart

Close